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Several G-rich synthetic oligodeoxyribonucleotides (ODNs) have shown promising biological 
properties, ranging from anticancer to anti-HIV activities. G-quadruplex formation was found to be 
a crucial prerequisite in determining these biological effects [1]. Aptamers exhibiting anti-HIV 
activity represent an important class of potential therapeutics [2]. Recently we described the 
synthesis and characterization of new d(TGGGAG) ODNs, conjugated with different aromatic 
groups at the 5’-end through a phosphodiester bond [3]. The modified sequences showed a parallel 
stranded tetramolecular G-quadruplexes CD profile and a pronounced anti-HIV-1 activity. 
Herein, with the aim to use d(TGGGAG) as a lead sequence for a  more effective anti-HIV 
agent, we propose the fully automated synthesis of new ODNs containing two d(TGGGAG) 
sequences whose 3-ends are joint by an hexaethylenglycole loop. CD analysis was undertaken on 
the 3’-3’ linked d(TGGGAG) hairpins in comparison with the corresponding unmodified 
oligomers. Besides, in order to study the influence of the conjugation at the ends of the harpin 
chains on their ability to stabilize quadruplex structures and on their anti-HIV activity, different 
conjugated oligomers have been studied. 
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